Diana Mandelker

16.2k citations
94 papers · 2.5k indexed · h-index 23

Diana Mandelker

85 papers receiving 2.5k citations

Peers

Diana Mandelker
Comparison fields: 5 of 95
  • Cancer Research 718
  • Oncology 867
  • Genetics 319
  • Pathology and Forensic Medicine 388
  • Molecular Biology 1.3k
Replace Debyani Chakravarty with:
Debyani Chakravarty United States
In Ah Kim South Korea
Coya Tapia Switzerland
Maryou Lambros United Kingdom
Matthew T. Chang United States
Alessia Ciarrocchi Italy
Pieter J.A. Eichhorn Singapore
Mark A. Pershouse United States
Oleg Schmidt‐Kittler United States
Yusuke Nakamura Japan
Diana Mandelker relative to Debyani Chakravarty United States Debyani Chakravarty's profile →
Citations per field
00.5×1.5×1.8×
Debyani Chakravarty · 1×
Citations per year

Countries citing papers authored by Diana Mandelker

Since Specialization
Citations

This map shows the geographic impact of Diana Mandelker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Mandelker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Mandelker more than expected).

Fields of papers citing papers by Diana Mandelker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Mandelker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Mandelker. The network helps show where Diana Mandelker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Diana Mandelker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Diana Mandelker Line = papers co-authored together Diana Mandelker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20241
4 20245
5 20247
6 202334
7 20232
8 20236
9 202314
10 20234
11 20235
12 20223
13 20223
14 202210
15 202117
16 202024
17 201921
18 201922
19 201446
20 2007446

About Diana Mandelker

Diana Mandelker is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 94 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (40 papers), Genetic factors in colorectal cancer (23 papers), BRCA gene mutations in cancer (13 papers), DNA Repair Mechanisms (10 papers), Cancer-related Molecular Pathways (9 papers), Multiple and Secondary Primary Cancers (9 papers), PARP inhibition in cancer therapy (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). The work is most often cited by research in Cancer Research (718 citations), Oncology (867 citations) and Genetics (319 citations). Diana Mandelker has collaborated with scholars based in United States, Ireland and Netherlands. Frequent co-authors include Sandra B. Gabelli, L. Mario Amzel, Chuan‐Hsiang Huang, Bert Vogelstein, Oleg Schmidt‐Kittler, Kenneth W. Kinzler, Marc Ladanyi, Yardena Samuels, Victor E. Velculescu and Meera Hameed. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026